Literature DB >> 19494135

PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors.

Atheir I Abbas1, Prem N Yadav, Wei-Dong Yao, Margaret I Arbuckle, Seth G N Grant, Marc G Caron, Bryan L Roth.   

Abstract

Here, we report that postsynaptic density protein of 95 kDa (PSD-95), a postsynaptic density scaffolding protein, classically conceptualized as being essential for the regulation of ionotropic glutamatergic signaling at the postsynaptic membrane, plays an unanticipated and essential role in mediating the actions of hallucinogens and atypical antipsychotic drugs at 5-HT(2A) and 5-HT(2C) serotonergic G-protein-coupled receptors. We show that PSD-95 is crucial for normal 5-HT(2A) and 5-HT(2C) expression in vivo and that PSD-95 maintains normal receptor expression by promoting apical dendritic targeting and stabilizing receptor turnover in vivo. Significantly, 5-HT(2A)- and 5-HT(2C)-mediated downstream signaling is impaired in PSD-95(null) mice, and the 5-HT(2A)-mediated head-twitch response is abnormal. Furthermore, the ability of 5-HT(2A) inverse agonists to normalize behavioral changes induced by glutamate receptor antagonists is abolished in the absence of PSD-95 in vivo. These results demonstrate that PSD-95, in addition to the well known role it plays in scaffolding macromolecular glutamatergic signaling complexes, profoundly modulates metabotropic 5-HT(2A) and 5-HT(2C) receptor function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494135      PMCID: PMC2836830          DOI: 10.1523/JNEUROSCI.1090-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  81 in total

1.  Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS.

Authors:  D A Clemett; T Punhani; M S Duxon; T P Blackburn; K C Fone
Journal:  Neuropharmacology       Date:  2000       Impact factor: 5.250

Review 2.  NMDA receptor hypofunction model of schizophrenia.

Authors:  J W Olney; J W Newcomer; N B Farber
Journal:  J Psychiatr Res       Date:  1999 Nov-Dec       Impact factor: 4.791

3.  RNA editing of the human serotonin 5-HT(2C) receptor delays agonist-stimulated calcium release.

Authors:  R D Price; E Sanders-Bush
Journal:  Mol Pharmacol       Date:  2000-10       Impact factor: 4.436

4.  The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.

Authors:  M L Carlsson; P Martin; M Nilsson; S M Sorensen; A Carlsson; S Waters; N Waters
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

5.  RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity.

Authors:  C M Niswender; S C Copeland; K Herrick-Davis; R B Emeson; E Sanders-Bush
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

6.  Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats.

Authors:  S Yamada; M Harano; N Annoh; K Nakamura; M Tanaka
Journal:  Biol Psychiatry       Date:  1999-09-15       Impact factor: 13.382

Review 7.  Serotonin and hallucinogens.

Authors:  G K Aghajanian; G J Marek
Journal:  Neuropsychopharmacology       Date:  1999-08       Impact factor: 7.853

8.  M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.

Authors:  G B Varty; V P Bakshi; M A Geyer
Journal:  Neuropsychopharmacology       Date:  1999-04       Impact factor: 7.853

9.  5-HT(2A) receptors stimulate mitogen-activated protein kinase via H(2)O(2) generation in rat renal mesangial cells.

Authors:  E L Greene; O Houghton; G Collinsworth; M N Garnovskaya; T Nagai; T Sajjad; V Bheemanathini; J S Grewal; R V Paul; J R Raymond
Journal:  Am J Physiol Renal Physiol       Date:  2000-04

Review 10.  The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.

Authors:  J D Jentsch; R H Roth
Journal:  Neuropsychopharmacology       Date:  1999-03       Impact factor: 7.853

View more
  56 in total

Review 1.  Serotonin receptor signaling and regulation via β-arrestins.

Authors:  Laura M Bohn; Cullen L Schmid
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

2.  Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

3.  Disrupting 5-HT(2A) receptor/PDZ protein interactions reduces hyperalgesia and enhances SSRI efficacy in neuropathic pain.

Authors:  Xavier Pichon; Anne S Wattiez; Carine Becamel; Ingrid Ehrlich; Joel Bockaert; Alain Eschalier; Philippe Marin; Christine Courteix
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

4.  HTS and rational drug design to generate a class of 5-HT(2C)-selective ligands for possible use in schizophrenia.

Authors:  Alan P Kozikowski; Sung Jin Cho; Niels H Jensen; John A Allen; Andreas M Svennebring; Bryan L Roth
Journal:  ChemMedChem       Date:  2010-08-02       Impact factor: 3.466

5.  Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.

Authors:  John A Allen; Julianne M Yost; Vincent Setola; Xin Chen; Maria F Sassano; Meng Chen; Sean Peterson; Prem N Yadav; Xi-ping Huang; Bo Feng; Niels H Jensen; Xin Che; Xu Bai; Stephen V Frye; William C Wetsel; Marc G Caron; Jonathan A Javitch; Bryan L Roth; Jian Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

Review 6.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345

7.  Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex.

Authors:  Noelle C Anastasio; Maria Fe Lanfranco; Marcy J Bubar; Patricia K Seitz; Sonja J Stutz; Andrew G McGinnis; Cheryl S Watson; Kathryn A Cunningham
Journal:  J Neurochem       Date:  2010-03-24       Impact factor: 5.372

Review 8.  Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.

Authors:  Andrea de Bartolomeis; Gianmarco Latte; Carmine Tomasetti; Felice Iasevoli
Journal:  Mol Neurobiol       Date:  2013-09-03       Impact factor: 5.590

9.  Individual Differences in Impulsive Action Reflect Variation in the Cortical Serotonin 5-HT2A Receptor System.

Authors:  Latham H L Fink; Noelle C Anastasio; Robert G Fox; Kenner C Rice; F Gerard Moeller; Kathryn A Cunningham
Journal:  Neuropsychopharmacology       Date:  2015-02-10       Impact factor: 7.853

10.  Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

Authors:  Jeremy M Veenstra-Vanderweele; Aurelio Galli; Christine Saunders; Michael Siuta; Sabrina D Robertson; Adeola R Davis; Jennifer Sauer; Heinrich J G Matthies; Paul J Gresch; David Airey; Craig W Lindsley; John A Schetz; Kevin D Niswender
Journal:  Neurochem Int       Date:  2013-09-30       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.